January is Cervical Health and Cervical Cancer Awareness Month. Did you know that cervical cancer is a preventable disease? Human papillomavirus (HPV) vaccination helps prevent infection with the HPV types that cause most cervical cancers. Schedule an appointment today with a UCLA gynecologist to discuss preventative measures for optimal cervical health and to get a pap smear and HPV screening if you are due! For more information about cervical cancer and to schedule an appointment >
To learn more about cervical cancer prevention and management >
To learn about cervical cancer clinical trials >
A vaccine is the most promising strategy for combating COVID-19 for the general population. But there’s less clarity about the safety of the vaccine for pregnant women since this population was not included in the COVID-19 vaccine trials. However, that doesn’t mean it’s unsafe for pregnant women. Many types of vaccines have been safely given to pregnant and lactating individuals for decades. So, the recommendation is that women and their health care provider should weigh the benefits and risks together. Experts from UCLA Obstetrics and Gynecology address some of the most pressing questions relating to pregnancy and the vaccine. Read more on the UCLA Health Connect Blog >
The BirthPlace Westwood and the BirthPlace Santa Monica are comprehensive maternity centers that provide private rooms, family-centered care and offer a wide range of services to make your birthing experience an event to cherish. More BirthPlace Information >
My Pregnancy: Weeks 1-20 >
My Pregnancy: Weeks 21-40 >
Giving to UCLA Obstetrics & Gynecology - UCLA OBGYN counts on your generous support to sustain our innovative programs, allowing us to provide exceptional gynecologic and obstetric health care for women by emphasizing the whole patient. Giving >
CERVICAL CANCER: The “Skyscraper-04” clinical trial is evaluating treatment options for cervical cancer. For this study, we are currently recruiting people who have recurrent (returned after previous treatment) cervical cancer. The purpose of this clinical trial is to evaluate the effects, good or bad, of tiragolumab plus atezolizumab and atezolizumab alone in patients with cervical cancer. For more details and enrollment information >
We in the UCLA Department of Obstetrics and Gynecology acknowledge and are deeply concerned regarding the disparities in the healthcare of women, particularly those of under-represented minorities. We recognize that the basis of this disparity is long-standing and sadly has its roots in racism and injustice against people of color, especially Black, Latino and Native American people. We concur with the statements released by other organizations that include National Medical Association (NMA), American College of Obstetricians and Gynecologists (ACOG), Society of Maternal-Fetal Medicine (SMFM), Society of Family Planning (SFP), and American Society of Reproductive Medicine (ASRM). We are committed as a department to identifying underlying implicit and explicit biases and eliminating them from our department in all areas including clinical service, research, and education.
Schedule an appointment: 310-794-7274.
UCLA OBGYN wants you to know that we are doing everything possible to ensure your health and safety during this unusual time. Given the concerns about the spread of the novel Coronavirus (COVID-19), we are scheduling or rescheduling many clinic visits as “telemedicine visits,” which can be conducted from home.
Video visit information >
